| Product Code: ETC12652054 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Leishmaniasis Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Leishmaniasis Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Leishmaniasis Market - Industry Life Cycle |
3.4 Portugal Leishmaniasis Market - Porter's Five Forces |
3.5 Portugal Leishmaniasis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Portugal Leishmaniasis Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
3.7 Portugal Leishmaniasis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Portugal Leishmaniasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Portugal Leishmaniasis Market Revenues & Volume Share, By Research Focus, 2021 & 2031F |
4 Portugal Leishmaniasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about leishmaniasis among pet owners and veterinarians |
4.2.2 Growing pet ownership rates in Portugal |
4.2.3 Rising incidence of leishmaniasis in dogs and humans in the region |
4.3 Market Restraints |
4.3.1 Lack of effective prevention and treatment options for leishmaniasis |
4.3.2 High costs associated with managing and treating leishmaniasis in pets |
4.3.3 Limited research and development efforts for new leishmaniasis treatments |
5 Portugal Leishmaniasis Market Trends |
6 Portugal Leishmaniasis Market, By Types |
6.1 Portugal Leishmaniasis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Leishmaniasis Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 Portugal Leishmaniasis Market Revenues & Volume, By Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.4 Portugal Leishmaniasis Market Revenues & Volume, By Visceral Leishmaniasis, 2021 - 2031F |
6.1.5 Portugal Leishmaniasis Market Revenues & Volume, By Mucocutaneous Leishmaniasis, 2021 - 2031F |
6.1.6 Portugal Leishmaniasis Market Revenues & Volume, By Diffuse Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.7 Portugal Leishmaniasis Market Revenues & Volume, By Post-Kala-Azar Dermal Leishmaniasis, 2021 - 2031F |
6.2 Portugal Leishmaniasis Market, By Diagnosis Method |
6.2.1 Overview and Analysis |
6.2.2 Portugal Leishmaniasis Market Revenues & Volume, By Microscopic Examination, 2021 - 2031F |
6.2.3 Portugal Leishmaniasis Market Revenues & Volume, By Serological Tests, 2021 - 2031F |
6.2.4 Portugal Leishmaniasis Market Revenues & Volume, By PCR Testing, 2021 - 2031F |
6.2.5 Portugal Leishmaniasis Market Revenues & Volume, By Culture Methods, 2021 - 2031F |
6.2.6 Portugal Leishmaniasis Market Revenues & Volume, By Montenegro Skin Test, 2021 - 2031F |
6.3 Portugal Leishmaniasis Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Portugal Leishmaniasis Market Revenues & Volume, By Antimonial Compounds, 2021 - 2031F |
6.3.3 Portugal Leishmaniasis Market Revenues & Volume, By Amphotericin B, 2021 - 2031F |
6.3.4 Portugal Leishmaniasis Market Revenues & Volume, By Miltefosine, 2021 - 2031F |
6.3.5 Portugal Leishmaniasis Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.3.6 Portugal Leishmaniasis Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.4 Portugal Leishmaniasis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Portugal Leishmaniasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Portugal Leishmaniasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Portugal Leishmaniasis Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 Portugal Leishmaniasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4.6 Portugal Leishmaniasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5 Portugal Leishmaniasis Market, By Research Focus |
6.5.1 Overview and Analysis |
6.5.2 Portugal Leishmaniasis Market Revenues & Volume, By Parasite Biology, 2021 - 2031F |
6.5.3 Portugal Leishmaniasis Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.5.4 Portugal Leishmaniasis Market Revenues & Volume, By Drug Resistance Mechanisms, 2021 - 2031F |
6.5.5 Portugal Leishmaniasis Market Revenues & Volume, By Vector Control Strategies, 2021 - 2031F |
6.5.6 Portugal Leishmaniasis Market Revenues & Volume, By Epidemiological Studies, 2021 - 2031F |
7 Portugal Leishmaniasis Market Import-Export Trade Statistics |
7.1 Portugal Leishmaniasis Market Export to Major Countries |
7.2 Portugal Leishmaniasis Market Imports from Major Countries |
8 Portugal Leishmaniasis Market Key Performance Indicators |
8.1 Number of veterinary clinics offering leishmaniasis prevention and treatment services |
8.2 Percentage of pet owners using preventative measures against leishmaniasis |
8.3 Research funding allocated towards leishmaniasis studies and treatment development |
9 Portugal Leishmaniasis Market - Opportunity Assessment |
9.1 Portugal Leishmaniasis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Portugal Leishmaniasis Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
9.3 Portugal Leishmaniasis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Portugal Leishmaniasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Portugal Leishmaniasis Market Opportunity Assessment, By Research Focus, 2021 & 2031F |
10 Portugal Leishmaniasis Market - Competitive Landscape |
10.1 Portugal Leishmaniasis Market Revenue Share, By Companies, 2024 |
10.2 Portugal Leishmaniasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here